Published in Medical Letter on the CDC and FDA, December 10th, 2006
CryoCor announced that as of October 30, 2006 it had enrolled 139 patients in its atrial fibrillation, or AF, pivotal trial, and that the remaining enrollment for its 160 patient pivotal trial may extend into the first half of 2007. CryoCor reported that as a result of slower enrollment in the last three months, it is considering opening several new clinical sites to complete the enrollment in the pivotal trial as soon as possible.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.